gvs 111 has been researched along with Alloxan Diabetes in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duzova, H; Gul, CC; Gurbuz, P; Taslidere, AC | 1 |
| Anisina, EA; Durnev, AD; Gudasheva, TA; Ostrovskaya, RU; Yagubova, SS; Zhanataev, AK | 1 |
| Akatlı, AN; Çiğ, B; Düzova, H; Gürbüz, P; Nazıroğlu, M | 1 |
| Bağ, HGG; Çakan, P; Durhan, M; Düzova, H; Gül, CC; Gürbüz, P; Kaya, GB; Taşlidere, AÇ; Yildiz, A | 1 |
| Gudascheva, TA; Ivanova, EA; Kapitsa, IG; Ostrovskaya, RU; Ozerova, IV; Seredenin, SB; Voronina, TA | 2 |
| Gudasheva, TA; Ivanova, EA; Kapitsa, IG; Michunskaya, AM; Ostrovskaya, RU; Ozerova, IV; Seredenin, SB; Taraban, KV; Voronina, TA; Zolotov, NN | 1 |
| Mamchur, VI; Pavlov, SV; Zhiliuk, VI | 1 |
8 other study(ies) available for gvs 111 and Alloxan Diabetes
| Article | Year |
|---|---|
Effects of noopept on ocular, pancreatic and renal histopathology in streptozotocin induced prepubertal diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Insulin; Kidney; Male; Pancreas; Rats; Sexual Maturation; Streptozocin | 2023 |
Neuroprotective Dipeptide Noopept Prevents DNA Damage in Mice with Modeled Prediabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dipeptides; DNA Damage; Hyperglycemia; Insulin-Secreting Cells; Kidney; Liver; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Neuroprotective Agents; Prediabetic State; Streptozocin | 2019 |
Noopept Attenuates Diabetes-Mediated Neuropathic Pain and Oxidative Hippocampal Neurotoxicity via Inhibition of TRPV1 Channel in Rats.
Topics: Animals; Diabetes Mellitus, Experimental; Dipeptides; Hippocampus; Male; Membrane Potential, Mitochondrial; Neuralgia; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar; TRPV Cation Channels | 2021 |
Effects of noopept on cognitive functions and pubertal process in rats with diabetes.
Topics: Animals; Blood Glucose; Brain-Derived Neurotrophic Factor; Cognition; Diabetes Mellitus, Experimental; Dipeptides; Insulin; Insulin Resistance; Male; Nerve Growth Factor; Neuroprotective Agents; Puberty; Rats; Rats, Sprague-Dawley | 2019 |
Efficiency of noopept in streptozotocin-induced diabetes in rats.
Topics: Animals; Antioxidants; Body Weight; Diabetes Mellitus, Experimental; Dipeptides; Hypoglycemic Agents; Male; Neuroprotective Agents; Nootropic Agents; Pain; Random Allocation; Rats; Rats, Wistar; Streptozocin | 2013 |
Comparative activity of proline-containing dipeptide noopept and inhibitor of dipeptidyl peptidase-4 sitagliptin in a rat model of developing diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Proline; Pyrazines; Rats; Rats, Wistar; Sitagliptin Phosphate; Triazoles | 2014 |
Noopept normalizes parameters of the incretin system in rats with experimental diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dipeptides; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Glucagon-Like Peptide 1; Hypoglycemic Agents; Incretins; Insulin; Male; Pancreas; Pyrazines; Rats, Wistar; Sitagliptin Phosphate; Triazoles | 2014 |
[Role of functional state of neuronal mitochondria of cerebral cortex in mechanisms of nootropic activity of neuroprotectors in rats with alloxan hyperglycemia].
Topics: Alloxan; Amnesia; Animals; Avoidance Learning; Cerebral Cortex; Cognition; Cytidine Diphosphate Choline; Diabetes Mellitus, Experimental; Dipeptides; Hyperglycemia; Male; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Neurons; Nootropic Agents; Pentoxifylline; Piracetam; Rats; Rats, Wistar | 2015 |